BCR-ABL1 is an abnormal gene present in certain types of leukemia. Genetic testing for BCR-ABL1 helps doctors diagnose these cancers and assess their response to treatment. If you or someone you know ...
Oncoguide System: A computerized interactive assistance system for the diagnosis and treatment of CML/MPN and MDS D. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This abstract ...
SUNNYVALE, Calif., Oct. 2, 2019 /PRNewswire/ -- Cepheid today announced that it has received clearance from the U.S. Food and Drug Administration for Xpert BCR-ABL Ultra for monitoring disease burden ...
Cyclophosphamide, Thalidomide, and Dexamethasone as Initial Therapy for Patients With Newly Diagnosed Multiple Myeloma in a Middle-Income Country: 7-Year Follow-Up A total of 962 cases of CML on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results